Yahoo5 Eylül 2026 07:18 TR3 saat önce
What Does Moderna (MRNA) Bird Flu Phase 3 Trial Mean For Its Growth?
Moderna (NasdaqGS:MRNA) has started a Phase 3 trial of its mRNA based bird flu vaccine, moving the program into late stage testing. The trial is supported by a major international partnership focused on pandemic preparedness. Moderna has tied the program to commitments for equitable global access, including reserved manufacturing capacity for low and middle income countries. This push into mRNA vaccines for emerging infectious diseases points to a wider theme in healthcare that is worth...
Haberin Tamamı Kaynağında
Burada gördüğün özet, haber sağlayıcısından geliyor; metnin devamı yayıncının sitesinde — Yahoo
Haberde Geçen Şirketler
Benzer Haberler
Is Moderna (MRNA) Fully Valued After Its New 2032 Convertible Notes?
Yahoo7 saat önce
Wall Street Has Cooled on Moderna After Its Stock Jumped Over 5X. But Does the mRNA Leader Have More Room to Run?
Yahoo10 saat önce
Micron and Western Digital Shares Skyrocket, What You Need To Know
Yahoo5 saat önce
FormFactor, Entegris, Penguin Solutions, Teradyne, and Marvell Technology Stocks Trade Up, What You Need To Know
Yahoo5 saat önce
SpaceX is now in your 401(k), and Musk is the risk
Yahoo6 saat önce